Elutia Inc. (ELUT) — SEC Filings
Elutia Inc. (ELUT) — 40 SEC filings. Latest: 4 (Apr 14, 2026). Includes 24 8-K, 6 10-Q, 2 DEF 14A.
Overview
Elutia Inc. (ELUT) is a publicly traded company tracked on ReadTheFiling. The most recent enriched filing is a 10-Q filed on Nov 12, 2025: Elutia Inc. reported a net loss of $3.868 million for the three months ended September 30, 2025, a significant decline from the net income of $1.286 million in the same period of 2024. For the nine months ended September 30, 2025, the net loss was $17.411 million, a substantial improvement from the
Sentiment Summary
Across 40 filings, the sentiment breakdown is: 1 bearish, 38 neutral, 1 mixed. The dominant filing sentiment for Elutia Inc. is neutral.
Filing Type Overview
Elutia Inc. (ELUT) has filed 1 4, 6 10-Q, 24 8-K, 2 DEF 14A, 2 10-K, 2 SC 13G, 2 SC 13G/A, 1 SC 13D/A with the SEC between Jan 2024 to Apr 2026.
Filings by Year
Recent SEC Filings (40)
Risk Profile
Risk Assessment: Of ELUT's 28 recent filings, 2 were flagged as high-risk, 16 as medium-risk, and 10 as low-risk. The overall risk profile suggests moderate risk with a balanced mix of positive and cautionary disclosures.
Financial Highlights
| Metric | Value |
|---|---|
| Revenue | $9.022M |
| Net Income | -$17.411M |
| EPS | N/A |
| Debt-to-Equity | N/A |
| Cash Position | $4.721M |
| Operating Margin | N/A |
| Total Assets | $29.407M |
| Total Debt | $73.325M |
Key Executives
- Dr. David L. Smith
Industry Context
Elutia Inc. operates in a sector likely influenced by healthcare innovation and regulatory landscapes. The company's financial performance, particularly its net loss and declining sales, suggests it may be facing challenges in market adoption, competitive pressures, or the high costs associated with research and development in its specific niche.
Top Tags
material-agreement (5) · company-name-change (5) · corporate-governance (4) · financials (4) · 10-Q (4) · financial-condition (3) · results-of-operations (3) · corporate-action (3) · Elutia Inc. (3) · Biotechnology (2)
Key Numbers
| Metric | Value | Context |
|---|---|---|
| Net Loss (Q3 2025) | $3.868M | Increased from $1.286M net income in Q3 2024 |
| Net Loss (9 Months 2025) | $17.411M | Improved from $44.888M net loss in 9 Months 2024 |
| Net Sales (Q3 2025) | $3.323M | Decreased from $3.662M in Q3 2024 |
| Net Sales (9 Months 2025) | $9.022M | Decreased from $11.651M in 9 Months 2024 |
| Gain on Warrant Revaluation (Q3 2025) | $5.098M | Contributed to reducing overall loss, compared to $12.653M gain in Q3 2024 |
| Gain on Warrant Revaluation (9 Months 2025) | $12.518M | Significant reversal from $15.321M loss in 9 Months 2024 |
| Litigation Costs, Net (Q3 2025) | $853K | Decreased significantly from $4.683M in Q3 2024 |
| Litigation Costs, Net (9 Months 2025) | $7.429M | Decreased from $8.757M in 9 Months 2024 |
| Warrant Liability (Sept 30, 2025) | $4.030M | Decreased from $16.076M at Dec 31, 2024 |
| Net Cash Used in Operating Activities (9 Months 2025) | $19.996M | Increased from $10.400M in 9 Months 2024, indicating higher cash burn |
| Net Loss (Q2 2025) | $9.61M | Significant improvement from $28.18M net loss in Q2 2024 |
| Net Loss (YTD Q2 2025) | $13.54M | Substantial improvement from $46.17M net loss in YTD Q2 2024 |
| Net Sales (Q2 2025) | $6.26M | Slight decrease from $6.29M in Q2 2024 |
| Net Sales (YTD Q2 2025) | $12.29M | Decrease from $12.98M in YTD Q2 2024 |
| Gross Profit (Q2 2025) | $3.06M | Increase from $2.80M in Q2 2024 |
Frequently Asked Questions
What are the latest SEC filings for Elutia Inc. (ELUT)?
Elutia Inc. has 40 recent SEC filings from Jan 2024 to Apr 2026, including 24 8-K, 6 10-Q, 2 DEF 14A. Each filing includes an AI-generated plain-English summary.
What is the overall sentiment of ELUT filings?
Across 40 filings, the sentiment breakdown is: 1 bearish, 38 neutral, 1 mixed. The dominant sentiment is neutral.
Where can I find Elutia Inc. SEC filings explained simply?
ReadTheFiling provides AI-powered plain-English summaries of all Elutia Inc. (ELUT) SEC filings, including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and insider trades.
What are the key financial highlights for Elutia Inc.?
Key financial highlights from Elutia Inc.'s most recent 10-Q include metrics such as revenue, net income, EPS, and debt ratios. Visit the filing detail page for the full breakdown.
What is the investment thesis for ELUT?
The investment thesis for ELUT includes bull, base, and bear case scenarios derived from AI analysis of recent SEC filings.
Who are the key executives at Elutia Inc.?
Key executives identified across Elutia Inc.'s filings include Dr. David L. Smith.
What are the main risk factors for Elutia Inc. stock?
Of ELUT's 28 assessed filings, 2 were flagged high-risk, 16 medium-risk, and 10 low-risk.
What are recent predictions and forward guidance from Elutia Inc.?
Forward guidance and predictions for Elutia Inc. are extracted from SEC filings as they are enriched.